Judit Kocsis

Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Sara A. Hurvitz, Luc Dirix, Judit Kocsis et al. · Journal of Clinical Oncology · 2013 · 391 citations

Medicine, Oncology, Pharmacology +17

Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer

Perri Rozenberg, Judit Kocsis, M. Saar et al. · International Journal of Cancer · 2013 · 57 citations · Full text

Medicine, Cancer Biology, Oncology +11

Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis

Judit Kocsis, Balázs Madaras, Éva Katalin Tóth et al. · Cell Stress and Chaperones · 2009 · 53 citations · Full text

Medicine, Molecular Biology, Oncology +11

Abstract GS3-01: GS3-01 EMERALD phase 3 trial of elacestrant versus standard of care endocrine therapy in patients with ER+/HER2- metastatic breast cancer: Updated results by duration of prior CDK4/6i in metastatic setting

Aditya Bardia, François‐Clément Bidard, Patrick Neven et al. · Cancer Research · 2023 · 42 citations

Medicine, Endocrinology, Oncology +17

The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk

Éva Katalin Tóth, Judit Kocsis, Balázs Madaras et al. · International Journal of Cancer · 2007 · 38 citations

Life Sciences, Genetics, Oncology +17